BioSpace News Archive

BioForest

CytoDyn’s Experimental Cancer and HIV Drug Shows Promise in Treating COVID-19

The company announced today, in what has been a series of announcements, that it had filed a second clinical trial protocol with the U.S. Food and Drug Administration (FDA) to treat severely sick COVID-19 patients with COVID-19.

April 1, 2020
·
3 min read
·
Mark Terry
Policy

Biopharma Update on the Novel Coronavirus: April 1

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 1, 2020.

April 1, 2020
·
8 min read
·
BioSpace Editorial Staff
Policy

FDA Ends Zolgensma Data Manipulation Investigation, Places No Penalties on Novartis

In a statement, the FDA said “objectionable conditions were found and documented” but did not meet the threshold for regulatory action against the Swiss pharma giant.

April 1, 2020
·
2 min read
·
Alex Keown
Business

VCs Tell Biotechs: Hunker Down, Manage Your Cash Carefully

“Companies active in the fight against COVID-19 will have plenty of funding, and those targeting severe unmet needs will weather the storm better than others. But, for the rest, it will be rough for the next 12 months,” said Otello Stampacchia, founder of Omega Funds.

April 1, 2020
·
3 min read
·
Gail Dutton
Grail’s Next-Gen Multi-Cancer Test Detects 50 Early-Stage Cancers with 93% Accuracy

The technology can detect more than 50 different cancer types across all stages. It has a false-positive rate of less than one percent and does all this testing on a single blood sample.

April 1, 2020
·
3 min read
·
Mark Terry
Policy

FDA Calls for Removal of Zantac, Ranitidine Products from the Market

Following months of concerns regarding the potential contamination of ranitidine-based products with known carcinogens, the U.S. Food and Drug Administration is asking manufacturers to immediately withdraw all prescription and over-the-counter drugs from the market.

April 1, 2020
·
3 min read
·
Alex Keown
Drug Development

Sanofi and Regeneron Launch Second Kevzara Trial Against COVID-19

The companies initiated a Phase II/III trial in Italy, Spain, Germany, France, Japan, Canada and Russia.

April 1, 2020
·
2 min read
·
Alex Keown
Policy

As COVID-19 Cases Rise, FDA Accelerates Development of Therapies

The U.S. Food and Drug Administration is expediting the development of novel therapies for the pandemic through an accelerated evaluation process.

April 1, 2020
·
2 min read
·
Alex Keown
Business

Some Doctors and Pharmacists Stockpiling COVID-19 Drugs is Becoming a Problem

On March 25, the American Medical Association, American Pharmacist Association and Americans Society of Health-System Pharmacists issued a statement in response to media reports that physicians and pharmacists were hoarding supplies of the drugs for their own use.

April 1, 2020
·
6 min read
·
Mark Terry
Genetown

Pandion Raises $80 Million Series B to Advance Autoimmune Therapies

The company’s therapies are designed to fix the immune system imbalance that causes autoimmune diseases.

April 1, 2020
·
2 min read
·
Mark Terry